These mutant mice have an increase in both the frequency of papilloma formation and their progression to malignancies, with hyperplasia additionally seen in the epidermis surrounding these tumours following DMBA/TPA administration, reflecting the importance of GRHL3 in maintaining a tumour-free environment within the epidermis. This evidence concerns the gene GRHL3 and neoplasm.